DocSym
β
Searchsearch
Search
(Y51.8) Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified confirmed
507 deaths with diagnosis centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
3% mortality rate associated with the disease centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
Diagnosis centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
Absence or low individual and public risk
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - what does this mean
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified are medications that act on the central nervous system to block the action of certain neurotransmitters, such as adrenaline, that can lead to a variety of symptoms, including increased heart rate, blood pressure, and anxiety. these medications work to reduce the activity of these neurotransmitters, allowing the patient to experience relief from symptoms.
What happens during the disease - centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
Centrally acting and adrenergic-neuron-blocking agents are medications that act on the central nervous system to block the action of certain neurotransmitters, such as adrenaline. this can lead to a decrease in blood pressure, heart rate, and respiration, as well as other side effects such as drowsiness, dizziness, and confusion. in some cases, these agents can also lead to an increased risk of stroke, heart attack, and other serious cardiovascular events.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging tests (e.g. X-rays, CT scans, MRIs)
- Electrocardiogram (ECG)
- Electromyography (EMG)
- Nerve conduction velocity (NCV) tests
- Neurological tests
- Genetic testing
- Psychological testing
Treatment and Medical Assistance
Main Goal: To treat the disease with centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified.
- Prescribe medications that act on the central nervous system.
- Administer drugs that inhibit the release of neurotransmitters.
- Prescribe drugs that block the action of adrenergic neurons.
- Prescribe drugs that affect the metabolism of neurotransmitters.
- Monitor the patient's response to the treatment.
- Adjust the dose of the medications as needed.
- Provide lifestyle modifications to help manage the disease.
- Refer the patient to a specialist for further evaluation and treatment.
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - Prevention
The best way to prevent centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified is to avoid exposure to any known risk factors such as certain medications, smoking, or alcohol. additionally, following a healthy diet and getting regular exercise can help to reduce the risk of developing this condition.